vs
Ispire Technology Inc.(ISPR)与奥驰亚(MO)财务数据对比。点击上方公司名可切换其他公司
奥驰亚的季度营收约是Ispire Technology Inc.的288.2倍($5.8B vs $20.3M)。奥驰亚净利率更高(19.1% vs -32.5%,领先51.7%)。奥驰亚同比增速更快(-2.1% vs -51.5%)。奥驰亚自由现金流更多($3.2B vs $-4.0M)。过去两年奥驰亚的营收复合增速更高(2.4% vs -17.8%)
Ispire科技是一家专注于先进雾化硬件及配套耗材研发、生产与销售的全球化科技企业,主要服务尼古丁及合法大麻消费市场,下设硬件、品牌大麻产品两大核心业务板块,覆盖北美、欧洲、亚太等核心市场,为B端合作商及终端用户提供合规创新的雾化解决方案。
奥驰亚集团是美国头部烟草企业,通过旗下子公司生产销售可燃烟草与口服类烟草相关产品,核心品牌包括万宝路香烟、Black & Mild雪茄及烟斗烟、哥本哈根、斯库尔等湿无烟烟草,以及on!口服尼古丁袋,产品主要供应批发商、分销商及大型零售客户。
ISPR vs MO — 直观对比
营收规模更大
MO
是对方的288.2倍
$20.3M
营收增速更快
MO
高出49.4%
-51.5%
净利率更高
MO
高出51.7%
-32.5%
自由现金流更多
MO
多$3.2B
$-4.0M
两年增速更快
MO
近两年复合增速
-17.8%
损益表 — Q2 2026 vs Q4 2025
| 指标 | ||
|---|---|---|
| 营收 | $20.3M | $5.8B |
| 净利润 | $-6.6M | $1.1B |
| 毛利率 | 17.1% | 62.1% |
| 营业利润率 | -33.9% | 28.2% |
| 净利率 | -32.5% | 19.1% |
| 营收同比 | -51.5% | -2.1% |
| 净利润同比 | 17.4% | -63.2% |
| 每股收益(稀释后) | $-0.12 | $0.67 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ISPR
MO
| Q4 25 | $20.3M | $5.8B | ||
| Q3 25 | $30.4M | $6.1B | ||
| Q2 25 | $20.1M | $6.1B | ||
| Q1 25 | $26.2M | $5.3B | ||
| Q4 24 | $41.8M | $6.0B | ||
| Q3 24 | $39.3M | $6.3B | ||
| Q2 24 | $37.3M | $6.2B | ||
| Q1 24 | $30.0M | $5.6B |
净利润
ISPR
MO
| Q4 25 | $-6.6M | $1.1B | ||
| Q3 25 | $-3.3M | $2.4B | ||
| Q2 25 | $-14.8M | $2.4B | ||
| Q1 25 | $-10.9M | $1.1B | ||
| Q4 24 | $-8.0M | $3.0B | ||
| Q3 24 | $-5.6M | $2.3B | ||
| Q2 24 | $-3.5M | $3.8B | ||
| Q1 24 | $-5.9M | $2.1B |
毛利率
ISPR
MO
| Q4 25 | 17.1% | 62.1% | ||
| Q3 25 | 17.0% | 62.8% | ||
| Q2 25 | 12.3% | 63.1% | ||
| Q1 25 | 18.2% | 61.8% | ||
| Q4 24 | 18.5% | 60.3% | ||
| Q3 24 | 19.5% | 60.8% | ||
| Q2 24 | 28.3% | 59.2% | ||
| Q1 24 | 20.4% | 58.8% |
营业利润率
ISPR
MO
| Q4 25 | -33.9% | 28.2% | ||
| Q3 25 | -8.9% | 53.2% | ||
| Q2 25 | -72.7% | 52.9% | ||
| Q1 25 | -40.4% | 34.0% | ||
| Q4 24 | -17.6% | 48.2% | ||
| Q3 24 | -13.4% | 50.4% | ||
| Q2 24 | -9.2% | 40.8% | ||
| Q1 24 | -18.8% | 48.0% |
净利率
ISPR
MO
| Q4 25 | -32.5% | 19.1% | ||
| Q3 25 | -10.7% | 39.1% | ||
| Q2 25 | -73.4% | 39.0% | ||
| Q1 25 | -41.5% | 20.5% | ||
| Q4 24 | -19.1% | 50.9% | ||
| Q3 24 | -14.2% | 36.6% | ||
| Q2 24 | -9.4% | 61.2% | ||
| Q1 24 | -19.7% | 38.2% |
每股收益(稀释后)
ISPR
MO
| Q4 25 | $-0.12 | $0.67 | ||
| Q3 25 | $-0.06 | $1.41 | ||
| Q2 25 | $-0.26 | $1.41 | ||
| Q1 25 | $-0.19 | $0.63 | ||
| Q4 24 | $-0.14 | $1.78 | ||
| Q3 24 | $-0.10 | $1.34 | ||
| Q2 24 | $-0.07 | $2.21 | ||
| Q1 24 | $-0.11 | $1.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $17.6M | $4.5B |
| 总债务越低越好 | — | $25.7B |
| 股东权益账面价值 | $-7.7M | $-3.5B |
| 总资产 | $84.4M | $35.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
ISPR
MO
| Q4 25 | $17.6M | $4.5B | ||
| Q3 25 | $22.7M | $3.5B | ||
| Q2 25 | $24.4M | $1.3B | ||
| Q1 25 | $23.5M | $4.7B | ||
| Q4 24 | $34.4M | $3.1B | ||
| Q3 24 | $37.7M | $1.9B | ||
| Q2 24 | $35.1M | $1.8B | ||
| Q1 24 | $39.5M | $3.6B |
总债务
ISPR
MO
| Q4 25 | — | $25.7B | ||
| Q3 25 | — | $25.7B | ||
| Q2 25 | — | $24.7B | ||
| Q1 25 | — | $26.1B | ||
| Q4 24 | — | $24.9B | ||
| Q3 24 | — | $25.2B | ||
| Q2 24 | — | $25.0B | ||
| Q1 24 | — | $25.0B |
股东权益
ISPR
MO
| Q4 25 | $-7.7M | $-3.5B | ||
| Q3 25 | $-1.8M | $-2.6B | ||
| Q2 25 | $604.7K | $-3.3B | ||
| Q1 25 | $14.8M | $-3.5B | ||
| Q4 24 | $24.2M | $-2.2B | ||
| Q3 24 | $30.7M | $-3.5B | ||
| Q2 24 | $34.5M | $-3.0B | ||
| Q1 24 | $35.9M | $-5.1B |
总资产
ISPR
MO
| Q4 25 | $84.4M | $35.0B | ||
| Q3 25 | $96.4M | $35.0B | ||
| Q2 25 | $102.2M | $32.3B | ||
| Q1 25 | $115.7M | $35.8B | ||
| Q4 24 | $132.0M | $35.2B | ||
| Q3 24 | $129.0M | $34.2B | ||
| Q2 24 | $122.6M | $34.4B | ||
| Q1 24 | $108.0M | $36.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-4.0M | $3.3B |
| 自由现金流经营现金流 - 资本支出 | $-4.0M | $3.2B |
| 自由现金流率自由现金流/营收 | -19.9% | 54.4% |
| 资本支出强度资本支出/营收 | 0.3% | 1.6% |
| 现金转化率经营现金流/净利润 | — | 2.93× |
| 过去12个月自由现金流最近4个季度 | $-14.2M | $9.1B |
8季度趋势,按日历期对齐
经营现金流
ISPR
MO
| Q4 25 | $-4.0M | $3.3B | ||
| Q3 25 | $-1.2M | $3.1B | ||
| Q2 25 | $4.7M | $205.0M | ||
| Q1 25 | $-12.5M | $2.7B | ||
| Q4 24 | $-3.2M | $3.3B | ||
| Q3 24 | $3.6M | $2.6B | ||
| Q2 24 | $-1.4M | $-75.0M | ||
| Q1 24 | $3.4M | $2.9B |
自由现金流
ISPR
MO
| Q4 25 | $-4.0M | $3.2B | ||
| Q3 25 | $-1.2M | $3.0B | ||
| Q2 25 | $3.7M | $173.0M | ||
| Q1 25 | $-12.7M | $2.7B | ||
| Q4 24 | $-3.2M | $3.3B | ||
| Q3 24 | $3.3M | $2.6B | ||
| Q2 24 | $-2.2M | $-104.0M | ||
| Q1 24 | $3.3M | $2.8B |
自由现金流率
ISPR
MO
| Q4 25 | -19.9% | 54.4% | ||
| Q3 25 | -3.9% | 50.1% | ||
| Q2 25 | 18.6% | 2.8% | ||
| Q1 25 | -48.4% | 51.0% | ||
| Q4 24 | -7.7% | 55.1% | ||
| Q3 24 | 8.5% | 41.2% | ||
| Q2 24 | -5.9% | -1.7% | ||
| Q1 24 | 10.9% | 51.0% |
资本支出强度
ISPR
MO
| Q4 25 | 0.3% | 1.6% | ||
| Q3 25 | 0.0% | 0.9% | ||
| Q2 25 | 4.8% | 0.5% | ||
| Q1 25 | 0.7% | 0.7% | ||
| Q4 24 | 0.1% | 0.8% | ||
| Q3 24 | 0.7% | 0.5% | ||
| Q2 24 | 2.0% | 0.5% | ||
| Q1 24 | 0.3% | 0.6% |
现金转化率
ISPR
MO
| Q4 25 | — | 2.93× | ||
| Q3 25 | — | 1.30× | ||
| Q2 25 | — | 0.09× | ||
| Q1 25 | — | 2.53× | ||
| Q4 24 | — | 1.10× | ||
| Q3 24 | — | 1.14× | ||
| Q2 24 | — | -0.02× | ||
| Q1 24 | — | 1.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ISPR
暂无分部数据
MO
| Smokeable Products Segment | $5.1B | 88% |
| Oral Tobacco Segment | $706.0M | 12% |